BERLIN, GERMANY — Anker, the global consumer electronics company known for its charging products and Soundcore audio devices, is entering the hearing aid market with new receiver-in-canal (RIC) devices powered by its proprietary THUS AI chip.
The company announced the move September 3 as part of a broader series of announcements surrounding IFA 2026 in Berlin. According to Anker’s announcement, the hearing aids will draw on technologies developed for its consumer audio products, including noise reduction, long battery life and fast charging.
Anker said additional details about the hearing aids will be provided in the coming months.
The entry is notable given Anker’s scale in the broader consumer electronics market. Founded in 2011, the company says it now serves more than 200 million customers across more than 180 countries and regions, with products spanning charging, audio and video, smart home, robotics, energy, health and creative technology.
Anker is also consolidating its previously distinct Anker, Soundcore, eufy, SOLIX and eufyMake brands under the Anker name as part of a broader corporate rebranding announced at IFA.
Bringing THUS AI to Hearing Health
At the center of Anker’s move into hearing aids is its proprietary THUS AI chip. The company is incorporating the technology across a new generation of audio products and now plans to bring the platform into hearing aids.
The move extends Anker’s existing experience in consumer audio, rechargeable devices and noise reduction into hearing health. However, the company has not yet disclosed detailed specifications, pricing, availability or how the hearing aids will be distributed and supported.
An OTC Market Still Finding Its Footing
Anker’s arrival comes at an interesting point in the development of the U.S. over-the-counter hearing aid market. Since the FDA’s OTC hearing aid regulations took effect in 2022, the category has attracted traditional hearing aid manufacturers, consumer electronics companies and a growing number of startups. Commercial results, however, have been mixed.
One of the most significant recent exits came when LXE Hearing announced it was winding down its U.S. operations after failing to identify what it described as a viable path forward following restructuring and efforts to pursue strategic transactions. LXE had been formed through the merger of Eargo and hearX and included the Eargo, Lexie Hearing and Go Hearing brands.
The challenges have not been limited to smaller companies. GN, one of the world’s major hearing technology companies and the company behind Jabra Enhance, has also been working toward profitability in its direct-to-consumer hearing business.
During GN’s Q2 2026 earnings discussion, CEO Peter Karlströmer described JabraEnhance.com as “very close to break-even”, while acknowledging that the company’s formal break-even target had been pushed back by several quarters.
The experience of companies already operating in the category highlights some of the broader challenges associated with OTC hearing care. Developing the device itself is only part of the equation, with consumer acquisition, support, returns, ongoing service and the economics of direct-to-consumer distribution all potentially affecting long-term viability.
At the same time, newer entrants continue to invest and expand in the market. ELEHEAR recently expanded its OTC hearing aid services with ElePro Plus, a tele-audiology program that provides users with access to licensed hearing professionals for remote hearing assessment, fitting adjustments and follow-up support.
The development reflects a broader evolution of the OTC model, with some companies moving beyond a primarily self-service device purchase toward hybrid approaches incorporating professional support.
A Different Kind of Entrant
Anker’s scale makes its entrance into hearing aids particularly noteworthy. Unlike many hearing technology startups, the company enters the category with an established global consumer brand, extensive experience in audio and rechargeable electronics, and an existing customer base numbering in the hundreds of millions.
Whether those advantages translate into success in hearing healthcare remains to be seen. The experience of companies already operating in OTC hearing aids suggests that strong technology and consumer recognition do not necessarily eliminate the challenges associated with customer acquisition, support and long-term profitability.
For now, Anker has disclosed relatively little about how its hearing aids will be positioned, sold or supported. The company says additional details will be announced in the coming months.
Source: Anker
